Christina Claus

1.2k total citations
19 papers, 553 citations indexed

About

Christina Claus is a scholar working on Oncology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Christina Claus has authored 19 papers receiving a total of 553 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 10 papers in Immunology and 8 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Christina Claus's work include Peptidase Inhibition and Analysis (7 papers), Immune Cell Function and Interaction (6 papers) and Immunotherapy and Immune Responses (5 papers). Christina Claus is often cited by papers focused on Peptidase Inhibition and Analysis (7 papers), Immune Cell Function and Interaction (6 papers) and Immunotherapy and Immune Responses (5 papers). Christina Claus collaborates with scholars based in Switzerland, United Kingdom and United States. Christina Claus's co-authors include Adrian F. Ochsenbein, Matthias S. Matter, Christian M. Schürch, Tamara Hilmenyuk, Christian Klein, Carsten Riether, Claudia Ferrara, Michael Hippler, Lutz Wobbe and Conrad W. Mullineaux and has published in prestigious journals such as Nature Medicine, Blood and PLoS ONE.

In The Last Decade

Christina Claus

18 papers receiving 542 citations

Peers

Countries citing papers authored by Christina Claus

Since Specialization

Citations

This map shows the geographic impact of Christina Claus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christina Claus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christina Claus more than expected).

Fields of papers citing papers by Christina Claus

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christina Claus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christina Claus. The network helps show where Christina Claus may publish in the future.

Co-authorship network of co-authors of Christina Claus

This figure shows the co-authorship network connecting the top 25 collaborators of Christina Claus. A scholar is included among the top collaborators of Christina Claus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christina Claus. Christina Claus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Altered levels of angiogenin and tRNA-derived fragments associate with severe asthma 2025 ·Scientific Reports ·Christina Claus, (unknown), (unknown), (unknown), Óscar Bottasso, Tania Maes, Ken R. Bracke, Guy Brusselle, (unknown), Ledit Ardusso, Silvana V. Spinelli	0
2	4-1BB agonist targeted to fibroblast activation protein α synergizes with radiotherapy to treat murine breast tumor models 2025 ·Journal for ImmunoTherapy of Cancer ·(unknown), (unknown), Leticia Fernández, Carlos E. de Andrea, (unknown), (unknown), Álvaro Teijeira, Carlos Luri‐Rey, Christina Claus, Tamara Tanos, Christian Klein, Pablo Umaña, Antonio Rullan, (unknown), María Collantes, Paloma Sánchez‐Mateos, Ignacio Melero, María E. Rodríguez-Ruiz	4
3	Combining mathematical modeling, in vitro data and clinical target expression to support bispecific antibody binding affinity selection: a case example with FAP-4-1BBL 2024 ·Frontiers in Pharmacology ·Javier Sánchez, Christina Claus, Christine McIntyre, Tamara Tanos, (unknown), Lena E. Friberg, Siv Jönsson, Nicolas Frances	1
4	A model‐based approach leveraging in vitro data to support dose selection from the outset: A framework for bispecific antibodies in immuno‐oncology 2023 ·CPT Pharmacometrics & Systems Pharmacology ·(unknown), Christina Claus, R. Albrecht, (unknown), (unknown), Christine McIntyre, Tamara Tanos, (unknown), Lena E. Friberg, Siv Jönsson, Nicolas Frances	2
5	The emerging landscape of novel 4-1BB (CD137) agonistic drugs for cancer immunotherapy 2023 ·mAbs ·Christina Claus, Claudia Ferrara, Christian Klein	70
6	Augmenting Efficacy of T-Cell Bispecific Antibodies in AML through a Tumor Stroma-Targeted 4-1BB Agonist 2021 ·Blood ·Gerulf Hänel, (unknown), Vesna Pulko, Christina Claus, Alexandra Leutbecher, Anetta Marcinek, (unknown), Veit Buecklein, Pablo Umaña, Christian Klein, Marion Subklewe	1
7	RG6076 (CD19-4-1BBL): CD19-Targeted 4-1BB Ligand Combination with Glofitamab As an Off-the-Shelf, Enhanced T-Cell Redirection Therapy for B-Cell Malignancies 2020 ·Blood ·Sylvia Herter, Johannes Sam, Claudia Ferrara, Sarah Diggelmann, Esther Bommer, Anne Schönle, Christina Claus, Marina Bacac, Christian Klein, Pablo Umaña	8
8	Abstract 6135: Tumor-bearing non-human primates: An unrivaled model for translational cancer immunology research 2020 ·Cancer Research ·Maurizio Ceppi, Michael Hettich, Volker Teichgräber, Wouter H. P. Driessen, Dietrich Tuerck, Estelle Marrer‐Berger, Stefan Evers, Flavio Crameri, Bruno Gomes, Jürgen Bachl, Christian Klein, Christina Claus, Maria Amann, Oliver Krieter, Greg Dugan, David L. Caudell, Jason M. Grayson, (unknown), (unknown)	4
9	Abstract LB-389: Combination of TYRP1-TCB, a novel T cell bispecific antibody for the treatment of melanoma, with immunomodulatory agents 2020 ·Cancer Research ·Valeria Nicolini, Inja Waldhauer, Anne Freimoser–Grundschober, Marine Richard, Linda Fahrni, Esther Bommer, Christina Claus, Johannes Sam, Sara Colombetti, Roger P.M. Sutmuller, Mitchell P. Levesque, Anja Irmisch, Conrad C. Bleul, (unknown), Marina Bacac, Ekkehard Moessner, Christian Klein, Pablo Umaña	6
10	Abstract 5621: FAP-4-1BBL: A novel versatile tumor-stroma targeted 4-1BB agonist for combination immunotherapy with checkpoint inhibitors, T-cell bispecific antibodies, and ADCC-mediating antibodies 2018 ·Cancer Research ·Johannes Sam, Christina Claus, Claudia Ferrara, Sabine M. Lang, Valeria Nicolini, Sara Colombetti, Volker Teichgräber, Stefan Evers, Marina Bacac, Pablo Umaña, Christian Klein	1
11	CD70 reverse signaling enhances NK cell function and immunosurveillance in CD27-expressing B-cell malignancies 2017 ·Blood ·(unknown), Carla A. Jaeger-Ruckstuhl, Tamara Hilmenyuk, Christina Claus, Jean‐Pierre Bourquin, Beat Bornhäuser, Ramin Radpour, Carsten Riether, Adrian F. Ochsenbein	32
12	Abstract 3634: A novel tumor-targeted 4-1BB agonist and its combination with T-cell bispecific antibodies: an off-the-shelf cancer immunotherapy alternative to CAR T-cells 2017 ·Cancer Research ·Christina Claus, Claudia Ferrara, Sabine M. Lang, R. Albrecht, Sylvia Herter, Maria Amann, (unknown), Johannes Sam, Sara Colombetti, Marina Bacac, Christian Klein, Pablo Umaña	4
13	CD27 Signaling Increases the Frequency of Regulatory T Cells and Promotes Tumor Growth 2012 ·Cancer Research ·Christina Claus, Carsten Riether, Christian M. Schürch, Matthias S. Matter, Tamara Hilmenyuk, Adrian F. Ochsenbein	129
14	Destruction of Lymphoid Organ Architecture and Hepatitis Caused by CD4+ T Cells 2011 ·PLoS ONE ·Matthias S. Matter, Tamara Hilmenyuk, Christina Claus, Romina Marone, Christian M. Schürch, Marianne Tinguely, Luigi Terracciano, Sanjiv A. Luther, Adrian F. Ochsenbein	10
15	Chronic myelogenous leukemia maintains specific CD8⁺ T cells through IL‐7 signaling 2010 ·European Journal of Immunology ·Sabine Mumprecht, Christian M. Schürch, (unknown), Christina Claus, Adrian F. Ochsenbein	8
16	Development of replication-defective lymphocytic choriomeningitis virus vectors for the induction of potent CD8+ T cell immunity 2010 ·Nature Medicine ·Lukas Flatz, Ahmed N. Hegazy, Andreas Bergthaler, Admar Verschoor, Christina Claus, Marylise Fernandez, Luca Gattinoni, Susan Johnson, Florian Kreppel, Stefan Kochanek, Maries van den Broek, Andreas Radbruch, Frédéric Lévy, Paul‐Henri Lambert, Claire-Anne Siegrist, Nicholas P. Restifo, Max Löhning, Adrian F. Ochsenbein, Gary J. Nabel, Daniel D. Pinschewer	106
17	Defective homing and impaired induction of cytotoxic T cells by BCR/ABL-expressing dendritic cells 2009 ·Blood ·Sabine Mumprecht, Christina Claus, Christian M. Schürch, (unknown), Matthias S. Matter, Adrian F. Ochsenbein	24
18	CD4⁺ T cell help improves CD8⁺ T cell memory by retained CD27 expression 2008 ·European Journal of Immunology ·Matthias S. Matter, Christina Claus, Adrian F. Ochsenbein	30
19	NAB1 Is an RNA Binding Protein Involved in the Light-Regulated Differential Expression of the Light-Harvesting Antenna of Chlamydomonas reinhardtii 2005 ·The Plant Cell ·Jan H. Mussgnug, Lutz Wobbe, (unknown), Christina Claus, Mary Hamilton, Andréas Fink, Uwe Kahmann, (unknown), Conrad W. Mullineaux, Michael Hippler, Jörg Nickelsen, Peter J. Nixon, Olaf Kruse	113

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact